Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026)
Powered by 
Analysis
Steris (STE) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 41.96% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 24.84% |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | 35.29% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 25.48% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 35.42% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 250.09% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | 11.09% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | 12.01% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 9.23% |
| 10 | Zimmer Biomet Holdings | 17.78 Bn | 17.37 Bn | 1.54 Bn | 16.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.23% |
| Mar 31, 2026 | 19.32% |
| Dec 31, 2025 | 20.59% |
| Sep 30, 2025 | 112.24% |
| Jun 30, 2025 | 41.25% |
| Mar 31, 2025 | 24.39% |
| Dec 31, 2024 | 14.29% |
| Sep 30, 2024 | 16.42% |
| Jun 30, 2024 | 68.30% |
| Mar 31, 2024 | 13.04% |
| Dec 31, 2023 | 4.28% |
| Sep 30, 2023 | -18.98% |
| Jun 30, 2023 | 47.20% |
| Mar 31, 2023 | 1.42% |
| Dec 31, 2022 | 14.47% |
| Sep 30, 2022 | -40.96% |
| Jun 30, 2022 | 24.83% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | 25.18% |
| Sep 30, 2021 | 1.18% |